Utah Medical Products, Inc.
US ˙ NasdaqGS ˙ US9174881089

SecurityUTMD / Utah Medical Products, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership5,871 shares
Latest Disclosed Value $ 363,943
Qube Research & Technologies Ltd reports 61.56% decrease in ownership of UTMD / Utah Medical Products, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 5,871 shares of Utah Medical Products, Inc. (US:UTMD) valued at $363,943 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 15,274 shares of Utah Medical Products, Inc.. This represents a change in shares of -61.56% during the quarter. The current value of the position is $384,727 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F UTAH MED PRODS COM 917488108 5,871 -9,403 -61.56 364 -57.49 0.0004
2026-02-17 2025-12-31 13F UTAH MED PRODS COM 917488108 15,274 1,786 13.24 855 0.59 0.0009
2025-11-14 2025-09-30 13F UTAH MED PRODS COM 917488108 13,488 948 7.56 849 19.07 0.0009
2025-08-14 2025-06-30 13F UTAH MED PRODS COM 917488108 12,540 -728 -5.49 714 -4.04 0.0007
2025-05-15 2025-03-31 13F UTAH MED PRODS COM 917488108 13,268 -799 -5.68 744 -14.00 0.0009
2025-02-14 2024-12-31 13F UTAH MED PRODS COM 917488108 14,067 4,343 44.66 865 32.92 0.0011
2024-11-14 2024-09-30 13F UTAH MED PRODS COM 917488108 9,724 4,117 73.43 651 73.80 0.0010
2024-08-14 2024-06-30 13F UTAH MED PRODS COM 917488108 5,607 1,004 21.81 375 14.37 0.0006
2024-05-14 2024-03-31 13F UTAH MED PRODS COM 917488108 4,603 3,590 354.39 327 284.71 0.0005
2024-02-13 2023-12-31 13F UTAH MED PRODS COM 917488108 1,013 1,013 85 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.